US committee for laboratory automation standards set up:
This article was originally published in Clinica
Executive Summary
A committee of government and industry representatives, together with academic and clinical scientists, has been formed in the US to examine the issues associated with clinical laboratory automation and sample handling, and to set standards for the use of these technologies. The Clinical Testing Automation Standards Steering Committee plans to draft standards for: automated specimen handling; specimen containers and specimen carriers; communication between instrument and computer; mechanical interface; error and exception handling; and system status/performance information. An update on standardisation activities will be presented at the American Association for Clinical Chemistry's annual meeting in Anaheim, CA, in July.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.